Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125608042 | 12560804 | 2 | F | 2016 | 20160718 | 20160715 | 20160801 | PER | US-PFIZER INC-2016341347 | PFIZER | 0.00 | M | Y | 74.00000 | KG | 20160801 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125608042 | 12560804 | 1 | PS | PALBOCICLIB | PALBOCICLIB | 1 | Oral | CYCLIC (ON DAYS 1-21 OF A 28 DAY) | 207103 | 125 | MG | ||||||||
| 125608042 | 12560804 | 2 | SS | CETUXIMAB | CETUXIMAB | 1 | Intravenous (not otherwise specified) | 250 MG/M2, WEEKLY | 0 | 250 | MG/M**2 | /wk | |||||||
| 125608042 | 12560804 | 3 | C | CEPHALEXIN. | CEPHALEXIN | 1 | UNK | 0 | |||||||||||
| 125608042 | 12560804 | 4 | C | CIPROFLOXACIN HCL | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125608042 | 12560804 | 5 | C | DOXYCYCLINE MONOHYDRATE | DOXYCYCLINE | 1 | UNK | 0 | |||||||||||
| 125608042 | 12560804 | 6 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | UNK | 0 | |||||||||||
| 125608042 | 12560804 | 7 | C | ONDANSETRON HCL | ONDANSETRON HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125608042 | 12560804 | 8 | C | OXYCODONE HYDROCHLORIDE. | OXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 125608042 | 12560804 | 9 | C | PROCHLORPERAZINE MALEATE. | PROCHLORPERAZINE MALEATE | 1 | UNK | 0 | |||||||||||
| 125608042 | 12560804 | 10 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 125608042 | 12560804 | 11 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 125608042 | 12560804 | 12 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | 0 | |||||||||||
| 125608042 | 12560804 | 13 | C | PREDNISONE. | PREDNISONE | 1 | UNK | 0 | |||||||||||
| 125608042 | 12560804 | 14 | C | ZOMETA | ZOLEDRONIC ACID | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125608042 | 12560804 | 1 | Squamous cell carcinoma of head and neck |
| 125608042 | 12560804 | 2 | Squamous cell carcinoma of head and neck |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125608042 | 12560804 | Disease progression | |
| 125608042 | 12560804 | Product use issue | |
| 125608042 | 12560804 | Squamous cell carcinoma of head and neck |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125608042 | 12560804 | 1 | 20160217 | 20160405 | 0 | |
| 125608042 | 12560804 | 2 | 20160217 | 20160406 | 0 |